{"id":27,"date":"2022-12-14T21:38:52","date_gmt":"2022-12-14T21:38:52","guid":{"rendered":"https:\/\/mpsdsehcp-dev-001.azurewebsites.net\/en\/mucopolysaccharidosis-mps\/?page_id=27"},"modified":"2023-12-04T09:14:15","modified_gmt":"2023-12-04T09:14:15","slug":"managing-mps","status":"publish","type":"page","link":"https:\/\/hcp.biomarin.com\/en-gb\/mps\/managing-mps\/","title":{"rendered":"Managing MPS"},"content":{"rendered":"
\n
<\/div>\n\t
<\/div>\n \t
<\/div>\n\t
\n\t\t
\n\t\t\t
\n\t\t\t \t\t\t\t\t\t\t\t\t\t\t\t

Managing MPS\n<\/h1>\n\t\t\t\t\t\t\t\t\t\t\t\t

Coordinated care for your patients: driving optimal outcomes in MPS management<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n

\n\t
\n\t\t
\n\t\t
\n

Coordinated, multidisciplinary care is critical in the management of complex multisystemic genetic diseases1<\/sup><\/h3>\n

Decades of ongoing research and clinical experience have produced a new era in the optimal management of mucopolysaccharidosis (MPS) disorders. This rapidly evolving standard of care for MPS relies on the geneticist at the centre of a healthcare delivery model that embodies coordinated, multidisciplinary care and provides physicians unmatched opportunities to change patients\u2019 lives.1\u20133<\/sup><\/p>\n

Optimising patient outcomes requires coordinated care.1\u20133<\/sup><\/strong><\/p>\n <\/div>\n \n

\n \n \n \n \n
\n
\n \"MPS <\/div>\n <\/figure>\n <\/div>\n \t\t<\/div>\n\t<\/div>\n<\/div>\n\n
\n
\n
\n \n
\n

Facilitating efficient coordination of clinicians across specialities3<\/sup><\/h3>\n

The heterogeneous and variable nature of MPS disorders necessitates a personalised approach to coordinated patient care.4<\/sup> The aim of coordinated care is to help patients achieve a greater quality of life, which includes:<\/p>\n